PRALUENT (alirocumab) ICD-10 Pocket Guide

Transcription

1 PRALUENT (alirocumab) ICD-10 Pocket Guide Your guide to ICD-10 coding for clinical atherosclerotic cardiovascular disease (ASCVD) INDICATION AND USAGE PRALUENT (alirocumab) is a PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) inhibitor antibody indicated as adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease, who require additional lowering of LDL-C. The effect of PRALUENT on cardiovascular morbidity and mortality has not been determined. PRALUENT is contraindicated in patients with a history of a serious hypersensitivity reaction to PRALUENT. Reactions have included hypersensitivity vasculitis and hypersensitivity reactions requiring hospitalization.

2 For additional support with ICD-10 coding, call PRALUENT ( ) and select 1, or contact your PRALUENT (alirocumab) field access specialist. Table of Contents ASCVD: Coronary Heart Disease Arteriosclerotic Heart Disease 4 With Angina 4 Other 5 Acute Coronary Syndromes 5 Myocardial Infarction 5 Acute, Active 5 History of Heart Attack (old) 5 Angina 5 Coronary Revascularization 5 ASCVD: Cerebrovascular Arteriosclerotic Cerebrovascular Disease 6 Ischemic Stroke 7 Transient Ischemic Attack (TIA) 9 History of Ischemic Stroke 10 With Residuals 10 Without Residuals 10 ASCVD: Peripheral Vascular Atherosclerosis of Peripheral and Other Non-coronary, Non-cerebral Vessels 11 Peripheral Artery Revascularization 19 Please use as many clinical ASCVD codes as needed to appropriately describe your patient s condition. Brought to you by Sanofi and Regeneron Pharmaceuticals, Inc. 2 3

3 Coronary Heart Disease Arteriosclerotic Heart Disease With Angina I25.10 Atherosclerotic heart disease of native coronary artery without angina pectoris I Atherosclerotic heart disease of native coronary artery with unstable angina pectoris I Atherosclerotic heart disease of native coronary artery with angina pectoris with documented spasm I Atherosclerotic heart disease of native coronary artery with other forms of angina pectoris I Atherosclerotic heart disease of native coronary artery with unspecified angina pectoris I Atherosclerosis of autologous vein coronary artery bypass graft(s) with unstable angina pectoris I Atherosclerosis of autologous vein coronary artery bypass graft(s) with angina pectoris with documented spasm I Atherosclerosis of autologous vein coronary artery bypass graft(s) with other forms of angina pectoris I Atherosclerosis of autologous vein coronary artery bypass graft(s) with unspecified angina pectoris I Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unstable angina pectoris I Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with angina pectoris with documented spasm I Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with other forms of angina pectoris I Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unspecified angina pectoris I Atherosclerosis of autologous artery coronary artery bypass graft(s) with unstable angina pectoris I Atherosclerosis of autologous artery coronary artery bypass graft(s) with angina pectoris with documented spasm I Atherosclerosis of autologous artery coronary artery bypass graft(s) with other forms of angina pectoris I Atherosclerosis of autologous artery coronary artery bypass graft(s) with unspecified angina pectoris I Atherosclerosis of coronary artery bypass graft(s), unspecified, with unstable angina pectoris I Atherosclerosis of coronary artery bypass graft(s), unspecified, with angina pectoris with documented spasm I Atherosclerosis of coronary artery bypass graft(s), unspecified, with other forms of angina pectoris I Atherosclerosis of coronary artery bypass graft(s), unspecified, with unspecified angina pectoris I Atherosclerosis of other coronary artery bypass graft(s) with unstable angina pectoris I Atherosclerosis of other coronary artery bypass graft(s) with angina pectoris with documented spasm I Atherosclerosis of other coronary artery bypass graft(s) with other forms of angina pectoris I Atherosclerosis of other coronary artery bypass graft(s) with unspecified angina pectoris I Atherosclerosis of coronary artery bypass graft(s) without angina pectoris I Atherosclerosis of native coronary artery of transplanted heart with unstable angina I Atherosclerosis of native coronary artery of transplanted heart with angina pectoris with documented spasm I Atherosclerosis of native coronary artery of transplanted heart with other forms of angina pectoris I Atherosclerosis of native coronary artery of transplanted heart with unspecified angina pectoris I Atherosclerosis of native coronary artery of transplanted heart without angina pectoris I Atherosclerosis of bypass graft of coronary artery of transplanted heart with unstable angina I Atherosclerosis of bypass graft of coronary artery of transplanted heart with angina pectoris with documented spasm I Atherosclerosis of bypass graft of coronary artery of transplanted heart with other forms of angina pectoris I Atherosclerosis of bypass graft of coronary artery of transplanted heart with unspecified angina pectoris I Atherosclerosis of bypass graft of coronary artery of transplanted heart without angina pectoris Arteriosclerotic Heart Disease (other) I25.82 Chronic total occlusion of coronary artery I25.83 Coronary atherosclerosis due to lipid rich plaque I25.84 Coronary atherosclerosis due to calcified coronary artery lesion Acute Coronary Syndromes I24.1 Dressler s syndrome (postmyocardial infarction syndrome) I24.0 Acute coronary thrombosis not resulting in myocardial infarction I24.8 Other forms of acute ischemic heart disease (includes acute and subacute coronary insufficiency) I23.7 Postinfarction angina Acute Myocardial Infarction (active) I21.09 ST elevation (STEMI) myocardial infarction involving other coronary artery of anterior wall I21.01 ST elevation (STEMI) myocardial infarction involving left main coronary artery I21.02 ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery I22.0 Subsequent ST elevation (STEMI) myocardial infarction of anterior wall I21.19 ST elevation (STEMI) myocardial infarction involving other coronary artery of inferior wall I22.1 Subsequent ST elevation (STEMI) myocardial infarction of inferior wall I21.11 ST elevation (STEMI) myocardial infarction involving right coronary artery I21.29 ST elevation (STEMI) myocardial infarction involving other sites I21.4 Non-ST elevation (NSTEMI) myocardial infarction I22.2 Subsequent non-st elevation (NSTEMI) myocardial infarction I21.21 ST elevation (STEMI) myocardial infarction involving left circumflex coronary artery I22.8 Subsequent ST elevation (STEMI) myocardial infarction of other sites I21.3 ST elevation (STEMI) myocardial infarction of unspecified site I22.9 Subsequent ST elevation (STEMI) myocardial infarction of unspecified site History of Heart Attack (old) I25.2 Old myocardial infarction Coronary Revascularization Z95.1 Presence of aortocoronary bypass graft (assigned when the patient is status post CABG) Z95.5 Presence of coronary angioplasty implant and graft (assigned when the patient is status post coronary artery angioplasty with stenting) Z98.61 Coronary angioplasty status (assigned when the patient is status post coronary artery angioplasty without stenting) PRALUENT (alirocumab) is contraindicated in patients with a history of a serious hypersensitivity reaction to PRALUENT. Reactions have included hypersensitivity vasculitis and hypersensitivity reactions requiring hospitalization. 4 5

4 Cerebrovascular Conditions Arteriosclerotic Cerebrovascular Disease I65.1 Occlusion and stenosis of basilar artery (not resulting in cerebral infarction) I65.21 Occlusion and stenosis of right carotid artery (not resulting in cerebral infarction) I65.22 Occlusion and stenosis of left carotid artery (not resulting in cerebral infarction) I65.23 Occlusion and stenosis of bilateral carotid arteries (not resulting in cerebral infarction) I65.29 Occlusion and stenosis of unspecified carotid artery (not resulting in cerebral infarction) I65.01 Occlusion and stenosis of right vertebral artery (not resulting in cerebral infarction) I65.02 Occlusion and stenosis of left vertebral artery (not resulting in cerebral infarction) I65.03 Occlusion and stenosis of bilateral vertebral arteries (not resulting in cerebral infarction) I65.09 Occlusion and stenosis of unspecified vertebral artery (not resulting in cerebral infarction) I65.8 Occlusion and stenosis of other precerebral arteries (not resulting in cerebral infarction) I65.9 Occlusion and stenosis of unspecified precerebral artery (not resulting in cerebral infarction) I66.01 Occlusion and stenosis of right middle cerebral artery (not resulting in cerebral infarction) I66.02 Occlusion and stenosis of left middle cerebral artery (not resulting in cerebral infarction) I66.03 Occlusion and stenosis of bilateral middle cerebral arteries (not resulting in cerebral infarction) I66.09 Occlusion and stenosis of unspecified middle cerebral artery (not resulting in cerebral infarction) I66.11 Occlusion and stenosis of right anterior cerebral artery (not resulting in cerebral infarction) I66.12 Occlusion and stenosis of left anterior cerebral artery (not resulting in cerebral infarction) I66.13 Occlusion and stenosis of bilateral anterior cerebral arteries (not resulting in cerebral infarction) I66.19 Occlusion and stenosis of unspecified anterior cerebral artery (not resulting in cerebral infarction) I66.21 Occlusion and stenosis of right posterior cerebral artery (not resulting in cerebral infarction) I66.22 Occlusion and stenosis of left posterior cerebral artery (not resulting in cerebral infarction) I66.23 Occlusion and stenosis of bilateral posterior cerebral arteries (not resulting in cerebral infarction) I66.29 Occlusion and stenosis of unspecified posterior cerebral artery (not resulting in cerebral infarction) I66.3 Occlusion and stenosis of cerebellar arteries (not resulting in cerebral infarction) I66.8 Occlusion and stenosis of other cerebral arteries (not resulting in cerebral infarction) I66.9 Occlusion and stenosis of unspecified cerebral artery (not resulting in cerebral infarction) I67.2 Cerebral atherosclerosis (not resulting in cerebral infarction) I67.81 Acute cerebrovascular insufficiency (not resulting in cerebral infarction) I67.82 Cerebral ischemia (not resulting in cerebral infarction) Ischemic Stroke I63.02 Cerebral infarction due to thrombosis of basilar artery I63.12 Cerebral infarction due to embolism of basilar artery I63.22 Cerebral infarction due to unspecified occlusion or stenosis of basilar arteries I Cerebral infarction due to thrombosis of right carotid artery I Cerebral infarction due to thrombosis of left carotid artery I Cerebral infarction due to thrombosis of unspecified carotid artery I Cerebral infarction due to embolism of right carotid artery I Cerebral infarction due to embolism of left carotid artery I Cerebral infarction due to embolism of unspecified carotid artery I Cerebral infarction due to unspecified occlusion or stenosis of right carotid arteries I Cerebral infarction due to unspecified occlusion or stenosis of left carotid arteries I Cerebral infarction due to unspecified occlusion or stenosis of unspecified carotid arteries I Cerebral infarction due to thrombosis of right vertebral artery I Cerebral infarction due to thrombosis of left vertebral artery I Cerebral infarction due to thrombosis of unspecified vertebral artery I Cerebral infarction due to embolism of right vertebral artery I Cerebral infarction due to embolism of left vertebral artery I Cerebral infarction due to embolism of unspecified vertebral artery I Cerebral infarction due to unspecified occlusion or stenosis of right vertebral arteries I Cerebral infarction due to unspecified occlusion or stenosis of left vertebral arteries I Cerebral infarction due to unspecified occlusion or stenosis of unspecified vertebral arteries I63.09 Cerebral infarction due to thrombosis of other precerebral artery I63.19 Cerebral infarction due to embolism of other precerebral artery I63.29 Cerebral infarction due to unspecified occlusion or stenosis of other precerebral arteries I63.00 Cerebral infarction due to thrombosis of unspecified precerebral artery I63.10 Cerebral infarction due to embolism of unspecified precerebral artery I63.20 Cerebral infarction due to unspecified occlusion or stenosis of unspecified precerebral arteries Hypersensitivity reactions (e.g., pruritus, rash, urticaria), including some serious events (e.g., hypersensitivity vasculitis and hypersensitivity reactions requiring hospitalization), have been reported with PRALUENT treatment. If signs or symptoms of serious allergic reactions occur, discontinue treatment with PRALUENT, treat according to the standard of care, and monitor until signs and symptoms resolve. 6 7

5 Ischemic Stroke (cont d) I63.30 Cerebral infarction due to thrombosis of unspecified cerebral artery I Cerebral infarction due to thrombosis of right middle cerebral artery I Cerebral infarction due to thrombosis of left middle cerebral artery I Cerebral infarction due to thrombosis of unspecified middle cerebral artery I Cerebral infarction due to thrombosis of right anterior cerebral artery I Cerebral infarction due to thrombosis of left anterior cerebral artery I Cerebral infarction due to thrombosis of unspecified anterior cerebral artery I Cerebral infarction due to thrombosis of right posterior cerebral artery I Cerebral infarction due to thrombosis of left posterior cerebral artery I Cerebral infarction due to thrombosis of unspecified posterior cerebral artery I Cerebral infarction due to thrombosis of right cerebellar artery I Cerebral infarction due to thrombosis of left cerebellar artery I Cerebral infarction due to thrombosis of unspecified cerebellar artery I63.39 Cerebral infarction due to thrombosis of other cerebral artery I63.6 Cerebral infarction due to cerebral venous thrombosis, nonpyogenic I63.40 Cerebral infarction due to embolism of unspecified cerebral artery I Cerebral infarction due to embolism of right middle cerebral artery I Cerebral infarction due to embolism of left middle cerebral artery I Cerebral infarction due to embolism of unspecified middle cerebral artery I Cerebral infarction due to embolism of right anterior cerebral artery I Cerebral infarction due to embolism of left anterior cerebral artery I Cerebral infarction due to embolism of unspecified anterior cerebral artery I Cerebral infarction due to embolism of right posterior cerebral artery I Cerebral infarction due to embolism of left posterior cerebral artery I Cerebral infarction due to embolism of unspecified posterior cerebral artery I Cerebral infarction due to embolism of right cerebellar artery I Cerebral infarction due to embolism of left cerebellar artery I Cerebral infarction due to embolism of unspecified cerebellar artery I63.49 Cerebral infarction due to embolism of other cerebral artery I63.50 Cerebral infarction due to unspecified occlusion or stenosis of unspecified cerebral artery I Cerebral infarction due to unspecified occlusion or stenosis of right middle cerebral artery I Cerebral infarction due to unspecified occlusion or stenosis of left middle cerebral artery I Cerebral infarction due to unspecified occlusion or stenosis of unspecified middle cerebral artery I Cerebral infarction due to unspecified occlusion or stenosis of right anterior cerebral artery I Cerebral infarction due to unspecified occlusion or stenosis of left anterior cerebral artery I Cerebral infarction due to unspecified occlusion or stenosis of unspecified anterior cerebral artery I Cerebral infarction due to unspecified occlusion or stenosis of right posterior cerebral artery I Cerebral infarction due to unspecified occlusion or stenosis of left posterior cerebral artery I Cerebral infarction due to unspecified occlusion or stenosis of unspecified posterior cerebral artery I Cerebral infarction due to unspecified occlusion or stenosis of right cerebellar artery I Cerebral infarction due to unspecified occlusion or stenosis of left cerebellar cerebral artery I Cerebral infarction due to unspecified occlusion or stenosis of unspecified cerebellar artery I63.59 Cerebral infarction due to unspecified occlusion or stenosis of other cerebral arteries I63.8 Other cerebral infarction I63.9 Cerebral infarction, unspecified Transient Ischemic Attack (TIA) G45.0 Vertebro-basilar artery syndrome G45.1 Carotid artery syndrome (hemispheric) G45.2 Multiple and bilateral precerebral artery syndromes G45.8 Other transient cerebral ischemic attacks and related syndromes G45.9 Transient cerebral ischemic attack, unspecified The most commonly occurring adverse reactions ( 5% of patients treated with PRALUENT and occurring more frequently than with placebo) are nasopharyngitis, injection site reactions, and influenza. 8 9

6 History of Ischemic Stroke With Residuals I69.31 Cognitive deficits following cerebral infarction I Aphasia following cerebral infarction I Dysphasia following cerebral infarction I Dysarthria following cerebral infarction I Fluency disorder following cerebral infarction I Other speech and language deficits following cerebral infarction I Hemiplegia and hemiparesis following cerebral infarction affecting unspecified side I Hemiplegia and hemiparesis following cerebral infarction affecting right dominant side I Hemiplegia and hemiparesis following cerebral infarction affecting left dominant side I Hemiplegia and hemiparesis following cerebral infarction affecting right non-dominant side I Hemiplegia and hemiparesis following cerebral infarction affecting left non-dominant side I Monoplegia of upper limb following cerebral infarction affecting unspecified side I Monoplegia of upper limb following cerebral infarction affecting right dominant side I Monoplegia of upper limb following cerebral infarction affecting left dominant side I Monoplegia of upper limb following cerebral infarction affecting right non-dominant side I Monoplegia of upper limb following cerebral infarction affecting left non-dominant side I Monoplegia of lower limb following cerebral infarction affecting unspecified side I Monoplegia of lower limb following cerebral infarction affecting right dominant side I Monoplegia of lower limb following cerebral infarction affecting left dominant side I Monoplegia of lower limb following cerebral infarction affecting right non-dominant side I Monoplegia of lower limb following cerebral infarction affecting left non-dominant side I Other paralytic syndrome following cerebral infarction affecting unspecified side I Other paralytic syndrome following cerebral infarction affecting right dominant side I Other paralytic syndrome following cerebral infarction affecting left dominant side I Other paralytic syndrome following cerebral infarction affecting right non-dominant side I Other paralytic syndrome following cerebral infarction affecting left non-dominant side I Other paralytic syndrome following cerebral infarction, bilateral I Other sequelae of cerebral infarction I Apraxia following cerebral infarction I Dysphagia following cerebral infarction I Facial weakness following cerebral infarction I Ataxia following cerebral infarction I Other sequelae of cerebral infarction I69.30 Unspecified sequelae of cerebral infarction Peripheral Vascular Conditions Atherosclerosis of Peripheral and Other Non-coronary, Non-cerebral Vessels I70.0 Atherosclerosis of aorta I70.1 Atherosclerosis of renal artery I Unspecified atherosclerosis of native arteries of extremities, right leg I Unspecified atherosclerosis of native arteries of extremities, left leg I Unspecified atherosclerosis of native arteries of extremities, bilateral legs I Unspecified atherosclerosis of native arteries of extremities, other extremity I Unspecified atherosclerosis of native arteries of extremities, unspecified extremity I Atherosclerosis of native arteries of extremities with intermittent claudication, right leg I Atherosclerosis of native arteries of extremities with intermittent claudication, left leg I Atherosclerosis of native arteries of extremities with intermittent claudication, bilateral legs I Atherosclerosis of native arteries of extremities with intermittent claudication, other extremity I Atherosclerosis of native arteries of extremities with intermittent claudication, unspecified extremity I Atherosclerosis of native arteries of extremities with rest pain, right leg I Atherosclerosis of native arteries of extremities with rest pain, left leg I Atherosclerosis of native arteries of extremities with rest pain, bilateral legs I Atherosclerosis of native arteries of extremities with rest pain, other extremity I Atherosclerosis of native arteries of extremities with rest pain, unspecified extremity Local injection site reactions including erythema/redness, itching, swelling, and pain/tenderness were reported more frequently in patients treated with PRALUENT (7.2% versus 5.1% for PRALUENT and placebo, respectively). Few patients discontinued treatment because of these reactions (0.2% versus 0.4% for PRALUENT and placebo, respectively), but patients receiving PRALUENT had a greater number of injection site reactions, had more reports of associated symptoms, and had reactions of longer average duration than patients receiving placebo. History of TIA or Stroke Without Residuals Z86.73 Personal history of transient ischemic attack (TIA) and cerebral infarction without residual deficits 10 11

7 Atherosclerosis of Peripheral and Other Non-coronary, Non-cerebral Vessels (cont d) I Atherosclerosis of native arteries of right leg with ulceration of thigh I Atherosclerosis of native arteries of right leg with ulceration of calf I Atherosclerosis of native arteries of right leg with ulceration of ankle I Atherosclerosis of native arteries of right leg with ulceration of heel and midfoot I Atherosclerosis of native arteries of right leg with ulceration of other part of foot I Atherosclerosis of native arteries of right leg with ulceration of other part of lower right leg I Atherosclerosis of native arteries of right leg with ulceration of unspecified site I Atherosclerosis of native arteries of left leg with ulceration of thigh I Atherosclerosis of native arteries of left leg with ulceration of calf I Atherosclerosis of native arteries of left leg with ulceration of ankle I Atherosclerosis of native arteries of left leg with ulceration of heel and midfoot I Atherosclerosis of native arteries of left leg with ulceration of other part of foot I Atherosclerosis of native arteries of left leg with ulceration of other part of lower left leg I Atherosclerosis of native arteries of left leg with ulceration of unspecified site I70.25 Atherosclerosis of native arteries of other extremities with ulceration I Atherosclerosis of native arteries of extremities with gangrene, right leg I Atherosclerosis of native arteries of extremities with gangrene, left leg I Atherosclerosis of native arteries of extremities with gangrene, bilateral legs I Atherosclerosis of native arteries of extremities with gangrene, other extremity I Atherosclerosis of native arteries of extremities with gangrene, unspecified extremity I Other atherosclerosis of native arteries of extremities, right leg I Other atherosclerosis of native arteries of extremities, left leg I Other atherosclerosis of native arteries of extremities, bilateral legs I Other atherosclerosis of native arteries of extremities, other extremity I Other atherosclerosis of native arteries of extremities, unspecified extremity Unspecified atherosclerosis of unspecified type of bypass graft(s) of the extremities, right leg I Unspecified atherosclerosis of unspecified type of bypass graft(s) of the extremities, left leg I Unspecified atherosclerosis of unspecified type of bypass graft(s) of the extremities, bilateral legs I Unspecified atherosclerosis of unspecified type of bypass graft(s) of the extremities, other extremity I Unspecified atherosclerosis of unspecified type of bypass graft(s) of the extremities, unspecified extremity I Atherosclerosis of unspecified type of bypass graft(s) of the extremities with intermittent claudication, right leg I Atherosclerosis of unspecified type of bypass graft(s) of the extremities with intermittent claudication, left leg I Atherosclerosis of unspecified type of bypass graft(s) of the extremities with intermittent claudication, bilateral legs I Atherosclerosis of unspecified type of bypass graft(s) of the extremities with intermittent claudication, other extremity I Atherosclerosis of unspecified type of bypass graft(s) of the extremities with intermittent claudication, unspecified extremity I Atherosclerosis of unspecified type of bypass graft(s) of the extremities with rest pain, right leg I Atherosclerosis of unspecified type of bypass graft(s) of the extremities with rest pain, left leg I Atherosclerosis of unspecified type of bypass graft(s) of the extremities with rest pain, bilateral legs I Atherosclerosis of unspecified type of bypass graft(s) of the extremities with rest pain, other extremity I Atherosclerosis of unspecified type of bypass graft(s) of the extremities with rest pain, unspecified extremity I Atherosclerosis of unspecified type of bypass graft(s) of the right leg with ulceration of thigh I Atherosclerosis of unspecified type of bypass graft(s) of the right leg with ulceration of calf I Atherosclerosis of unspecified type of bypass graft(s) of the right leg with ulceration of ankle I Atherosclerosis of unspecified type of bypass graft(s) of the right leg with ulceration of heel and midfoot I Atherosclerosis of unspecified type of bypass graft(s) of the right leg with ulceration of other part of foot I Atherosclerosis of unspecified type of bypass graft(s) of the right leg with ulceration of other part of lower leg I Atherosclerosis of unspecified type of bypass graft(s) of the right leg with ulceration of unspecified site I Atherosclerosis of unspecified type of bypass graft(s) of the left leg with ulceration of thigh I Atherosclerosis of unspecified type of bypass graft(s) of the left leg with ulceration of calf I Atherosclerosis of unspecified type of bypass graft(s) of the left leg with ulceration of ankle I Atherosclerosis of unspecified type of bypass graft(s) of the left leg with ulceration of heel and midfoot I Atherosclerosis of unspecified type of bypass graft(s) of the left leg with ulceration of other part of foot I Atherosclerosis of unspecified type of bypass graft(s) of the left leg with ulceration of other part of lower leg I Atherosclerosis of unspecified type of bypass graft(s) of the left leg with ulceration of unspecified site I70.35 Atherosclerosis, unspecified type of bypass graft of other extremity, with ulceration I Atherosclerosis of unspecified type of bypass graft(s) of the extremities with gangrene, right leg I Atherosclerosis of unspecified type of bypass graft(s) of the extremities with gangrene, left leg I Atherosclerosis of unspecified type of bypass graft(s) of the extremities with gangrene, bilateral legs I Atherosclerosis of unspecified type of bypass graft(s) of the extremities with gangrene, other extremity I Atherosclerosis of unspecified type of bypass graft(s) of the extremities with gangrene, unspecified extremity I Other atherosclerosis of unspecified type of bypass graft(s) of the extremities, right leg I Other atherosclerosis of unspecified type of bypass graft(s) of the extremities, left leg I Other atherosclerosis of unspecified type of bypass graft(s) of the extremities, bilateral legs I Other atherosclerosis of unspecified type of bypass graft(s) of the extremities, other extremity I Other atherosclerosis of unspecified type of bypass graft(s) of the extremities, unspecified extremity Neurocognitive events were reported in 0.8% of patients treated with PRALUENT and 0.7% of patients treated with placebo. Confusion or memory impairment were reported more frequently by those treated with PRALUENT (0.2% for each) than in those treated with placebo (<0.1% for each)

8 Atherosclerosis of Peripheral and Other Non-coronary, Non-cerebral Vessels (cont d) I Unspecified atherosclerosis of nonbiological bypass graft(s) of the extremities, right leg I Unspecified atherosclerosis of nonbiological bypass graft(s) of the extremities, left leg I Unspecified atherosclerosis of nonbiological bypass graft(s) of the extremities, bilateral legs I Unspecified atherosclerosis of nonbiological bypass graft(s) of the extremities, other extremity I Unspecified atherosclerosis of nonbiological bypass graft(s) of the extremities, unspecified extremity I Atherosclerosis of nonbiological bypass graft(s) of the extremities with intermittent claudication, right leg I Atherosclerosis of nonbiological bypass graft(s) of the extremities with intermittent claudication, left leg I Atherosclerosis of nonbiological bypass graft(s) of the extremities with intermittent claudication, bilateral legs I Atherosclerosis of nonbiological bypass graft(s) of the extremities with intermittent claudication, other extremity I Atherosclerosis of nonbiological bypass graft(s) of the extremities with intermittent claudication, unspecified extremity I Atherosclerosis of nonbiological bypass graft(s) of the extremities with rest pain, right leg I Atherosclerosis of nonbiological bypass graft(s) of the extremities with rest pain, left leg I Atherosclerosis of nonbiological bypass graft(s) of the extremities with rest pain, bilateral legs I Atherosclerosis of nonbiological bypass graft(s) of the extremities with rest pain, other extremity I Atherosclerosis of nonbiological bypass graft(s) of the extremities with rest pain, unspecified extremity I Atherosclerosis of nonbiological bypass graft(s) of the right leg with ulceration of thigh I Atherosclerosis of nonbiological bypass graft(s) of the right leg with ulceration of calf I Atherosclerosis of nonbiological bypass graft(s) of the right leg with ulceration of ankle I Atherosclerosis of nonbiological bypass graft(s) of the right leg with ulceration of heel and midfoot I Atherosclerosis of nonbiological bypass graft(s) of the right leg with ulceration of other part of foot I Atherosclerosis of nonbiological bypass graft(s) of the right leg with ulceration of other part of lower leg I Atherosclerosis of nonbiological bypass graft(s) of the right leg with ulceration of unspecified site I Atherosclerosis of nonbiological bypass graft(s) of the left leg with ulceration of thigh I Atherosclerosis of nonbiological bypass graft(s) of the left leg with ulceration of calf I Atherosclerosis of nonbiological bypass graft(s) of the left leg with ulceration of ankle I Atherosclerosis of nonbiological bypass graft(s) of the left leg with ulceration of heel and midfoot I Atherosclerosis of nonbiological bypass graft(s) of the left leg with ulceration of other part of foot I Atherosclerosis of nonbiological bypass graft(s) of the left leg with ulceration of other part of lower leg I Atherosclerosis of nonbiological bypass graft(s) of the left leg with ulceration of unspecified site I70.65 Atherosclerosis of nonbiological bypass graft(s) of other extremity with ulceration I Atherosclerosis of nonbiological bypass graft(s) of the extremities with gangrene, right leg I Atherosclerosis of nonbiological bypass graft(s) of the extremities with gangrene, left leg I Atherosclerosis of nonbiological bypass graft(s) of the extremities with gangrene, bilateral legs I Atherosclerosis of nonbiological bypass graft(s) of the extremities with gangrene, other extremity I Atherosclerosis of nonbiological bypass graft(s) of the extremities with gangrene, unspecified extremity I Other atherosclerosis of nonbiological bypass graft(s) of the extremities, right leg I Other atherosclerosis of nonbiological bypass graft(s) of the extremities, left leg I Other atherosclerosis of nonbiological bypass graft(s) of the extremities, bilateral legs I Other atherosclerosis of nonbiological bypass graft(s) of the extremities, other extremity I Other atherosclerosis of nonbiological bypass graft(s) of the extremities, unspecified extremity I Unspecified atherosclerosis of other type of bypass graft(s) of the extremities, right leg I Unspecified atherosclerosis of other type of bypass graft(s) of the extremities, left leg I Unspecified atherosclerosis of other type of bypass graft(s) of the extremities, bilateral legs I Unspecified atherosclerosis of other type of bypass graft(s) of the extremities, other extremity I Unspecified atherosclerosis of other type of bypass graft(s) of the extremities, unspecified extremity I Atherosclerosis of other type of bypass graft(s) of the extremities with intermittent claudication, right leg I Atherosclerosis of other type of bypass graft(s) of the extremities with intermittent claudication, left leg I Atherosclerosis of other type of bypass graft(s) of the extremities with intermittent claudication, bilateral legs I Atherosclerosis of other type of bypass graft(s) of the extremities with intermittent claudication, other extremity I Atherosclerosis of other type of bypass graft(s) of the extremities with intermittent claudication, unspecified extremity I Atherosclerosis of other type of bypass graft(s) of the extremities with rest pain, right leg I Atherosclerosis of other type of bypass graft(s) of the extremities with rest pain, left leg I Atherosclerosis of other type of bypass graft(s) of the extremities with rest pain, bilateral legs I Atherosclerosis of other type of bypass graft(s) of the extremities with rest pain, other extremity I Atherosclerosis of other type of bypass graft(s) of the extremities with rest pain, unspecified extremity I Atherosclerosis of other type of bypass graft(s) of the right leg with ulceration of thigh I Atherosclerosis of other type of bypass graft(s) of the right leg with ulceration of calf I Atherosclerosis of other type of bypass graft(s) of the right leg with ulceration of ankle I Atherosclerosis of other type of bypass graft(s) of the right leg with ulceration of heel and midfoot I Atherosclerosis of other type of bypass graft(s) of the right leg with ulceration of other part of foot I Atherosclerosis of other type of bypass graft(s) of the right leg with ulceration of other part of lower leg I Atherosclerosis of other type of bypass graft(s) of the right leg with ulceration of unspecified site Liver-related disorders (primarily related to abnormalities in liver enzymes) were reported in 2.5% of patients treated with PRALUENT and 1.8% of patients treated with placebo, leading to treatment discontinuation in 0.4% and 0.2% of patients, respectively. Increases in serum transaminases to greater than 3 times the upper limit of normal occurred in 1.7% of patients treated with PRALUENT and 1.4% of patients treated with placebo

9 Atherosclerosis of Peripheral and Other Non-coronary, Non-cerebral Vessels (cont d) I Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of thigh I Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of calf I Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of ankle I Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of heel and midfoot I Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of other part of foot I Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of other part of lower leg I Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of unspecified site I70.75 Atherosclerosis of other type of bypass graft(s) of other extremity with ulceration I Atherosclerosis of other type of bypass graft(s) of the extremities with gangrene, right leg I Atherosclerosis of other type of bypass graft(s) of the extremities with gangrene, left leg I Atherosclerosis of other type of bypass graft(s) of the extremities with gangrene, bilateral legs I Atherosclerosis of other type of bypass graft(s) of the extremities with gangrene, other extremity I Atherosclerosis of other type of bypass graft(s) of the extremities with gangrene, unspecified extremity I Other atherosclerosis of other type of bypass graft(s) of the extremities, right leg I Other atherosclerosis of other type of bypass graft(s) of the extremities, left leg I Other atherosclerosis of other type of bypass graft(s) of the extremities, bilateral legs I Other atherosclerosis of other type of bypass graft(s) of the extremities, other extremity I Other atherosclerosis of other type of bypass graft(s) of the extremities, unspecified extremity I Unspecified atherosclerosis of autologous vein bypass graft(s) of the extremities, right leg I Unspecified atherosclerosis of autologous vein bypass graft(s) of the extremities, left leg I Unspecified atherosclerosis of autologous vein bypass graft(s) of the extremities, bilateral legs I Unspecified atherosclerosis of autologous vein bypass graft(s) of the extremities, other extremity I Unspecified atherosclerosis of autologous vein bypass graft(s) of the extremities, unspecified extremity I Atherosclerosis of autologous vein bypass graft(s) of the extremities with intermittent claudication, right leg I Atherosclerosis of autologous vein bypass graft(s) of the extremities with intermittent claudication, left leg I Atherosclerosis of autologous vein bypass graft(s) of the extremities with intermittent claudication, bilateral legs I Atherosclerosis of autologous vein bypass graft(s) of the extremities with intermittent claudication, other extremity I Atherosclerosis of autologous vein bypass graft(s) of the extremities with intermittent claudication, unspecified extremity I Atherosclerosis of autologous vein bypass graft(s) of the extremities with rest pain, right leg I Atherosclerosis of autologous vein bypass graft(s) of the extremities with rest pain, left leg I Atherosclerosis of autologous vein bypass graft(s) of the extremities with rest pain, bilateral legs I Atherosclerosis of autologous vein bypass graft(s) of the extremities with rest pain, other extremity I Atherosclerosis of autologous vein bypass graft(s) of the extremities with rest pain, unspecified extremity I Atherosclerosis of autologous vein bypass graft(s) of the right leg with ulceration of thigh I Atherosclerosis of autologous vein bypass graft(s) of the right leg with ulceration of calf I Atherosclerosis of autologous vein bypass graft(s) of the right leg with ulceration of ankle I Atherosclerosis of autologous vein bypass graft(s) of the right leg with ulceration of heel and midfoot I Atherosclerosis of autologous vein bypass graft(s) of the right leg with ulceration of other part of foot I Atherosclerosis of autologous vein bypass graft(s) of the right leg with ulceration of other part of lower leg I Atherosclerosis of autologous vein bypass graft(s) of the right leg with ulceration of unspecified site I Atherosclerosis of autologous vein bypass graft(s) of the left leg with ulceration of thigh I Atherosclerosis of autologous vein bypass graft(s) of the left leg with ulceration of calf I Atherosclerosis of autologous vein bypass graft(s) of the left leg with ulceration of ankle I Atherosclerosis of autologous vein bypass graft(s) of the left leg with ulceration of heel and midfoot I Atherosclerosis of autologous vein bypass graft(s) of the left leg with ulceration of other part of foot I Atherosclerosis of autologous vein bypass graft(s) of the left leg with ulceration of other part of lower leg I Atherosclerosis of autologous vein bypass graft(s) of the left leg with ulceration of unspecified site I70.45 Atherosclerosis of autologous vein bypass graft(s) of other extremity with ulceration I Atherosclerosis of autologous vein bypass graft(s) of the extremities with gangrene, right leg I Atherosclerosis of autologous vein bypass graft(s) of the extremities with gangrene, left leg I Atherosclerosis of autologous vein bypass graft(s) of the extremities with gangrene, bilateral legs I Atherosclerosis of autologous vein bypass graft(s) of the extremities with gangrene, other extremity I Atherosclerosis of autologous vein bypass graft(s) of the extremities with gangrene, unspecified extremity I Other atherosclerosis of autologous vein bypass graft(s) of the extremities, right leg I Other atherosclerosis of autologous vein bypass graft(s) of the extremities, left leg I Other atherosclerosis of autologous vein bypass graft(s) of the extremities, bilateral legs I Other atherosclerosis of autologous vein bypass graft(s) of the extremities, other extremity I Other atherosclerosis of autologous vein bypass graft(s) of the extremities, unspecified extremity The most common adverse reactions leading to treatment discontinuation in patients treated with PRALUENT were allergic reactions (0.6% versus 0.2% for PRALUENT and placebo, respectively) and elevated liver enzymes (0.3% versus <0.1%). PRALUENT is a human monoclonal antibody. As with all therapeutic proteins, there is a potential for immunogenicity with PRALUENT

10 Atherosclerosis of Peripheral and Other Non-coronary, Non-cerebral Vessels (cont d) I Unspecified atherosclerosis of nonautologous biological bypass graft(s) of the extremities, right leg I Unspecified atherosclerosis of nonautologous biological bypass graft(s) of the extremities, left leg I Unspecified atherosclerosis of nonautologous biological bypass graft(s) of the extremities, bilateral legs I Unspecified atherosclerosis of nonautologous biological bypass graft(s) of the extremities, other extremity I Unspecified atherosclerosis of nonautologous biological bypass graft(s) of the extremities, unspecified extremity I Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with intermittent claudication, right leg I Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with intermittent claudication, left leg I Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with intermittent claudication, bilateral legs I Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with intermittent claudication, other extremity I Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with intermittent claudication, unspecified extremity I Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with rest pain, right leg I Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with rest pain, left leg I Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with rest pain, bilateral legs I Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with rest pain, other extremity I Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with rest pain, unspecified extremity I Atherosclerosis of nonautologous biological bypass graft(s) of the right leg with ulceration of thigh I Atherosclerosis of nonautologous biological bypass graft(s) of the right leg with ulceration of calf I Atherosclerosis of nonautologous biological bypass graft(s) of the right leg with ulceration of ankle I Atherosclerosis of nonautologous biological bypass graft(s) of the right leg with ulceration of heel and midfoot I Atherosclerosis of nonautologous biological bypass graft(s) of the right leg with ulceration of other part of foot I Atherosclerosis of nonautologous biological bypass graft(s) of the right leg with ulceration of other part of lower leg I Atherosclerosis of nonautologous biological bypass graft(s) of the right leg with ulceration of unspecified site I Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of thigh I Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of calf I Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of ankle I Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of heel and midfoot I Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of other part of foot I Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of other part of lower leg I Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of unspecified site I70.55 Atherosclerosis of nonautologous biological bypass graft(s) of other extremity with ulceration I Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with gangrene, right leg I Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with gangrene, left leg I Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with gangrene, bilateral legs I Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with gangrene, other extremity I Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with gangrene, unspecified extremity I Other atherosclerosis of nonautologous biological bypass graft(s) of the extremities, right leg I Other atherosclerosis of nonautologous biological bypass graft(s) of the extremities, left leg I Other atherosclerosis of nonautologous biological bypass graft(s) of the extremities, bilateral legs I Other atherosclerosis of nonautologous biological bypass graft(s) of the extremities, other extremity I Other atherosclerosis of nonautologous biological bypass graft(s) of the extremities, unspecified extremity I70.8 Atherosclerosis of other arteries I70.90 Unspecified atherosclerosis I70.91 Generalized atherosclerosis I70.92 Chronic total occlusion of artery of extremities I73.9 Peripheral vascular disease, unspecified (assigned for PVD and PAD) Peripheral Artery Revascularization Z Peripheral vascular angioplasty status with implants and grafts (assigned when the patient is status post peripheral artery angioplasty with stenting) Z98.62 Peripheral vascular angioplasty status (assigned when the patient is status post peripheral artery angioplasty without stenting) PRALUENT (alirocumab) is contraindicated in patients with a history of a serious hypersensitivity reaction to PRALUENT. Reactions have included hypersensitivity vasculitis and hypersensitivity reactions requiring hospitalization

11 Frequently Used Codes For My Office Notes Use this section to keep track of the ICD-10 diagnosis codes that your office frequently uses when prescribing PRALUENT (alirocumab) or enrolling patients in MyPRALUENT. ICD-10 Diagnosis Code Code Description Hypersensitivity reactions (e.g., pruritus, rash, urticaria), including some serious events (e.g., hypersensitivity vasculitis and hypersensitivity reactions requiring hospitalization), have been reported with PRALUENT treatment. If signs or symptoms of serious allergic reactions occur, discontinue treatment with PRALUENT, treat according to the standard of care, and monitor until signs and symptoms resolve

12 Important Safety Information PRALUENT (alirocumab) is contraindicated in patients with a history of a serious hypersensitivity reaction to PRALUENT. Reactions have included hypersensitivity vasculitis and hypersensitivity reactions requiring hospitalization. Hypersensitivity reactions (e.g., pruritus, rash, urticaria), including some serious events (e.g., hypersensitivity vasculitis and hypersensitivity reactions requiring hospitalization), have been reported with PRALUENT treatment. If signs or symptoms of serious allergic reactions occur, discontinue treatment with PRALUENT, treat according to the standard of care, and monitor until signs and symptoms resolve. The most commonly occurring adverse reactions ( 5% of patients treated with PRALUENT and occurring more frequently than with placebo) are nasopharyngitis, injection site reactions, and influenza. Local injection site reactions including erythema/redness, itching, swelling, and pain/tenderness were reported more frequently in patients treated with PRALUENT (7.2% versus 5.1% for PRALUENT and placebo, respectively). Few patients discontinued treatment because of these reactions (0.2% versus 0.4% for PRALUENT and placebo, respectively), but patients receiving PRALUENT had a greater number of injection site reactions, had more reports of associated symptoms, and had reactions of longer average duration than patients receiving placebo. Neurocognitive events were reported in 0.8% of patients treated with PRALUENT and 0.7% of patients treated with placebo. Confusion or memory impairment were reported more frequently by those treated with PRALUENT (0.2% for each) than in those treated with placebo (<0.1% for each). Liver-related disorders (primarily related to abnormalities in liver enzymes) were reported in 2.5% of patients treated with PRALUENT and 1.8% of patients treated with placebo, leading to treatment discontinuation in 0.4% and 0.2% of patients, respectively. Increases in serum transaminases to greater than 3 times the upper limit of normal occurred in 1.7% of patients treated with PRALUENT and 1.4% of patients treated with placebo. The most common adverse reactions leading to treatment discontinuation in patients treated with PRALUENT were allergic reactions (0.6% versus 0.2% for PRALUENT and placebo, respectively) and elevated liver enzymes (0.3% versus <0.1%). PRALUENT is a human monoclonal antibody. As with all therapeutic proteins, there is a potential for immunogenicity with PRALUENT. If you have questions about ICD-10 or need more information, call a MyPRALUENT care specialist at PRALUENT ( ) or contact your field access specialist